Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)
DOI: 10.1007/s00280-024-04741-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 26.12.2024. Verfasst von Miki Takenaka Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-85…. Hauptthemen laut MEDLINE: Sunitinib, Carcinoma, Renal Cell, Kidney Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. m-takenaka@pharm.showa-u.ac.jp.
- Department of Clinical Pharmacology and Therapeutics, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of Pharmacy, Gunma University Hospital, Maebashi, Japan.
- Department of Urology, Showa University Hospital, Tokyo, Japan.
- Department of Urology, Showa University Fujigaoka Hospital, Yokohama, Japan.
- Pelvic Reconstructive Surgery, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.
ORCID-Profile: Miki Takenaka Sato, Takuya Araki, Hideaki Yashima, Jun Morita, Yoshiko Maeda, Masayuki Ohbayashi, Noriko Kohyama, Yoshio Ogawa, Takashi Fukagai, Mari Kogo
Zitieren
APA
Sato, M. T., Araki, T., Yashima, H., Ishikawa, Y., Morita, J., Maeda, Y., Ohbayashi, M., Kohyama, N., Ogawa, Y., Fukagai, T., Yamamoto, K., & Kogo, M. (2025). Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment. Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04741-w
Vancouver
Sato MT, Araki T, Yashima H, Ishikawa Y, Morita J, Maeda Y, et al. Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment. Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-024-04741-w
BibTeX
@article{Sato2025,
author = {Sato, Miki Takenaka and Araki, Takuya and Yashima, Hideaki and Ishikawa, Yuya and Morita, Jun and Maeda, Yoshiko and Ohbayashi, Masayuki and Kohyama, Noriko and Ogawa, Yoshio and Fukagai, Takashi and Yamamoto, Koujirou and Kogo, Mari},
title = {Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
volume = {95},
number = {1},
doi = {10.1007/s00280-024-04741-w}
}
EUVIMED